Insilico Medicine vs Recursion — Comparison

Insilico Medicine

Generative AI and Automation for Longevity and Sustainability

I notice that the reviews section is empty and the social mentions only show YouTube titles repeating "Insilico Medicine AI" without any actual review content or user feedback. Without substantive user reviews, comments, or detailed social media discussions, I cannot provide a meaningful summary of what users think about Insilico Medicine's strengths, weaknesses, pricing, or overall reputation. To generate an accurate user sentiment analysis, I would need access to the actual content of reviews, comments, or more detailed social media posts about their AI drug discovery platform.

Recursion

Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us

Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas Leveraging the Power of Patient Data in AI-Drug Discovery Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

Insilico Medicine

Recursion

Insilico Medicine

Recursion

Insilico Medicine

Recursion